NSCLC New TKI shows Effectiveness in EGFR-Resistance Mutation

被引：0
|
作者：
Manych, Matthias
机构：
来源：
PNEUMOLOGIE | 2015年 / 69卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [31] Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC
    Koyama, Kenichi
    Miura, Satoru
    Watanabe, Satoshi
    Shoji, Satoshi
    Koshio, Jun
    Hayashi, Yoshiki
    Ishikawa, Daisuke
    Sato, Ko
    Miyabayashi, Takao
    Okajima, Masaaki
    Ota, Takeshi
    Tanaka, Tomohiro
    Matsumoto, Naoya
    Kuriyama, Hideyuki
    Abe, Tetsuya
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Kondo, Rie
    Tanaka, Hiroshi
    Kikuchi, Toshiaki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC
    Imamura, Fumio
    Inoue, Takako
    Kunimasa, Kei
    Kubota, Aki
    Kuhara, Hanako
    Tamiya, Motohiro
    Nishino, Kazumi
    Kimura, Madoka
    Kuno, Kika
    Kawachi, Hayato
    Kumagai, Toru
    LUNG CANCER MANAGEMENT, 2020, 9 (02)
  • [33] Time to EGFR-TKI Treatment for Patients with Advanced NSCLC and EGFR Activating Mutation in a Tertiary Cancer Center
    Le Guevelou, Jennifer
    Dugue, Audrey
    Richard, Nicolas
    Dubos, Catherine
    Do, Pascal
    Danhier, Serge
    Lerouge, Delphine
    Bonneau, Jessica
    Blanc, Cecile
    Gervais, Radj
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1229 - S1229
  • [34] Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC
    Paz-Ares, Luis
    Soulieres, Denis
    Moecks, Joachim
    Bara, Ilze
    Mok, Tony
    Klughammer, Barbara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (08) : 1519 - 1539
  • [35] Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations
    Choi, Junyoung
    Yoon, Shinkyo
    Kim, Deokhoon
    Moon, Yong Wha
    Lee, Chang Hoon
    Seo, Seyoung
    Cheon, Jaekyung
    Gho, Yong Song
    Kim, Changhoon
    Lee, Eung Ryoung
    Kim, Soo-Youl
    Lee, Kyoungmin
    Ha, Joo Young
    Park, Sook Ryun
    Kim, Sang-We
    Park, Kang-Seo
    Lee, Dae Ho
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1708 - +
  • [36] Possible new mechanisms of primary drug resistance in NSCLC with EGFR mutation treated with Osimertinib
    Shao, Lujing
    Li, Tong
    Jia, Xinyan
    Zhang, Xinyu
    Li, Qi
    Dong, Chunyan
    IUBMB LIFE, 2025, 77 (02)
  • [37] The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
    Wang, Chunyu
    Lu, Xiaotong
    Zhou, Zongmei
    Wang, Jingbo
    Hui, Zhouguang
    Liang, Jun
    Feng, QinFu
    Chen, Dongfu
    Xiao, Zefen
    Lv, Jima
    Wang, Xiaozhen
    Wang, Xin
    Zhang, Tao
    Deng, Lei
    Wang, Wenqing
    Xiao, Jianping
    Li, Junling
    Bi, Nan
    Wang, Luhua
    JOURNAL OF CANCER, 2019, 10 (09): : 1985 - 1990
  • [38] Disease monitoring and TKI resistance mutations of EGFR mutation-positive NSCLC patients via circulating tumor DNA.
    Woestmann, Corinna
    Ju, Christine
    Hinzmann, Bernd
    Yaung, Stephanie J.
    Thomas, Michael
    Heussel, Claus Peter
    Kriegsmann, Mark
    Meister, Michael
    Schneider, Marc
    Herth, Felix
    Muley, Thomas
    Wehnl, Birgit
    Palma, John F.
    Jiang, Yuqiu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Acquired resistance to EGFR-TKI in an uncommon G719S EGFR mutation
    Osoegawa, Atsushi
    Hashimoto, Takafumi
    Takumi, Yohei
    Abe, Miyuki
    Kobayashi, Ryoji
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    CANCER SCIENCE, 2018, 109 : 1101 - 1101
  • [40] Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S
    Osoegawa, A.
    Hashimoto, T.
    Takumi, Y.
    Kobayashi, R.
    Miyawaki, M.
    Takeuchi, H.
    Okamoto, T.
    Sugio, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2251 - S2251
12345